DADC
SAGE

D.A. Davidson & Co’s Sage Therapeutics SAGE Stock Holding History

D.A. Davidson & Co’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,536
Closed -$217K – 1156
2018
Q3 		$217K Sell
1,536
-34
-2% -$5.25K ﹤0.01% 1050
2018
Q2 		$246K Sell
1,570
-153
-9% -$24K ﹤0.01% 948
2018
Q1 		$278K Hold
1,723
– – 0.01% 886
2017
Q4 		$284K Buy
+1,723
New +$167K 0.01% 871
2017
Q3 		– Sell
-767
Closed -$61K – 1817
2017
Q2 		$61K Sell
767
-50
-6% -$3.62K ﹤0.01% 1462
2017
Q1 		$58K Sell
817
-134
-14% -$7.85K ﹤0.01% 1465
2016
Q4 		$47K Buy
+951
New +$44.8K ﹤0.01% 1615

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return